Key updates in ALL at EHA 2020
VJHemOnc Podcast
00:00
Response Rates and Treatment Options for ALL Patients
This chapter explores the efficacy and toxicity of two novel agents used as second-line treatments for patients with ALL, showing better response rates compared to conventional chemotherapy. The duration of response between the two agents is also examined, along with a study comparing total body irradiation with a top-aside based conditioning in children and adolescents with acute lymphoblastic leukemia.
Transcript
Play full episode
